Cardiovascular and Metabolic Market Research and Competitive Intelligence Leaders
by
![]() |
![]() |
![]() |
![]() |
![]() |
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
About CVrg
Our Team
Careers
Contact
Home
CardioVascular
Acute Coronary Syndromes
Atrial Fibrillation & Stroke Prevention in AFib
Dyslipidemia/Atherosclerosis
Heart Failure
Peripheral Arterial Disease
Pulmonary Hypertension
Venous Thrombosis
Metabolic
Chronic Kidney Disease
Metabolic Dysfunction-Associated Steatohepatitis
Obesity
Type 1 Diabetes
Type 2 Diabetes
Conferences
ACC
EASL
ATS
HF-ESC
ERA
ADA
ESC
EASD
ERS
ASN
AASLD
AHA
ASH
Dr. Poyner joined CVrg in 2009, after 15 years in the pharmaceutical industry, gaining expertise in drug delivery systems and cardiometabolic therapeutic areas. An accomplished competitive intelligence analyst, Dr Poyner is a qualified Six Sigma Green Belt, and possesses a proven ability to deliver timely and effective client focused information management solutions, enhanced by exceptional communication skills. She is well respected and well regarded by peers and senior management across the pharma industry. She was awarded Fellowship of the Royal Society of Chemistry in 2014 in recognition of her accomplishments. She received her BSc and Ph.D. in Chemistry from the University of London.